West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
Sales | 483,400 | 412,800 | 392,300 | 372,500 | 395,800 |
Cost of Goods | 330,000 | 295,200 | 277,500 | 265,000 | 261,200 |
Gross Profit | 153,400 | 117,600 | 114,800 | 107,500 | 134,600 |
Operating Expenses | 81,400 | 76,100 | 75,400 | 67,300 | 73,000 |
Operating Income | 72,000 | 41,700 | 39,900 | 40,200 | 61,800 |
Interest Expense | 9,700 | 10,600 | 13,500 | 11,100 | 10,400 |
Other Income | 3,800 | 800 | 2,000 | 1,200 | 800 |
Pre-tax Income | 66,100 | 31,900 | 28,400 | 30,300 | 52,200 |
Income Tax | 23,200 | 9,300 | 8,600 | 10,100 | 16,100 |
Net Income Continuous | 42,900 | 22,600 | 19,700 | 20,000 | 35,900 |
Net Income Discontinuous | -11,000 | -4,200 | -24,900 | -18,400 | 2,800 |
Net Income | $31,900 | $18,400 | $-5,200 | $1,600 | $38,700 |
EPS Basic Total Ops | 0.55 | 0.32 | -0.09 | 0.03 | 0.65 |
EPS Basic Continuous Ops | 0.74 | 0.39 | 0.35 | 0.35 | 0.60 |
EPS Basic Discontinuous Ops | -0.19 | -0.07 | -0.44 | -0.32 | 0.05 |
EPS Diluted Total Ops | 0.55 | 0.32 | -0.09 | 0.03 | 0.64 |
EPS Diluted Continuous Ops | 0.74 | 0.39 | 0.34 | 0.35 | 0.60 |
EPS Diluted Discontinuous Ops | -0.19 | -0.07 | -0.43 | -0.32 | 0.05 |
EBITDA(a) | $103,200 | $72,900 | $71,800 | $70,400 | $92,600 |